Provided by Tiger Trade Technology Pte. Ltd.

Pulse Biosciences

18.73
-0.5600-2.90%
Post-market: 18.36-0.3700-1.98%19:36 EST
Volume:166.27K
Turnover:3.13M
Market Cap:1.27B
PE:-17.34
High:19.57
Open:18.94
Low:18.54
Close:19.29
52wk High:26.30
52wk Low:12.56
Shares:67.77M
Float Shares:17.44M
Volume Ratio:0.31
T/O Rate:0.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0799
EPS(LYR):-1.0800
ROE:-74.45%
ROA:-42.37%
PB:15.74
PE(LYR):-17.34

Loading ...

BRIEF-Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Dec 20, 2025

Pulse Biosciences Grants Inducement Stock Options to New Employees

Reuters
·
Dec 20, 2025

Pulse Biosciences Wins FDA IDE Approval for nPulse Cardiac Catheter Study

Reuters
·
Dec 18, 2025

Pulse Biosciences Announces FDA Ide Approval to Initiate Its Npulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation

THOMSON REUTERS
·
Dec 18, 2025

Pulse Biosciences Partners with MD Anderson to Study Thyroid Cancer Treatment

Reuters
·
Dec 09, 2025

Pulse Biosciences, Inc. Announces Initiation of Research Collaboration for the Treatment of Benign and Malignant Thyroid Tumors With Npulse™ Technology

THOMSON REUTERS
·
Dec 09, 2025

BRIEF-Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Nov 22, 2025

Pulse Biosciences Grants Stock Options to New Employees Under Inducement Plan

Reuters
·
Nov 22, 2025

Pulse Biosciences Updates Investors on Product Advancements

TIPRANKS
·
Nov 13, 2025

Pulse Biosciences Inc. to Present at Stifel 2025 Healthcare Conference

Reuters
·
Nov 07, 2025

Pulse Biosciences FY2025 Q3 Earnings Call Summary and Q&A Highlights: Initial Revenue and Strategic Clinical Advancements

Earnings Call
·
Nov 06, 2025

Pulse Biosciences (PLSE) Earnings Transcript

Motley Fool Transcribing
·
Nov 06, 2025

Oppenheimer Keeps Their Buy Rating on Pulse Biosciences (PLSE)

TIPRANKS
·
Nov 06, 2025

Pulse Biosciences Q3 EPS $(0.29) Beats $(0.31) Estimate, Sales $86.000K Miss $500.000K Estimate

Benzinga
·
Nov 06, 2025

Pulse Biosciences Q3 Income From Operations USD -20.367 Million

Reuters
·
Nov 06, 2025

Pulse Biosciences Q3 EPS USD -0.29

THOMSON REUTERS
·
Nov 06, 2025

Pulse Biosciences Inc expected to post a loss of 31 cents a share - Earnings Preview

Reuters
·
Nov 04, 2025

Pulse Biosciences Inc. Announces Date for Upcoming Annual Stockholders Meeting

Reuters
·
Oct 28, 2025

Pulse Biosciences enrolls first patient in NANOCLAMP AF study

TIPRANKS
·
Oct 24, 2025

Pulse Biosciences Announces First Enrollment in the Nanoclamp Af Study

THOMSON REUTERS
·
Oct 24, 2025